---
title: "OSS: Q2 revenue up 62%, record bookings, and guidance raised to 25%-30% growth for 2026"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294990017.md"
description: "Q2 2026 saw 62% revenue growth and record bookings, driven by both defense and commercial markets. Gross margin was 39.1%, with strong cash reserves and no debt. Full-year revenue growth guidance was raised to 25%-30% on the back of a robust pipeline and expanding customer base.Based on DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-08-05T15:45:10.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294990017.md)
  - [en](https://longbridge.com/en/news/294990017.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294990017.md)
---

# OSS: Q2 revenue up 62%, record bookings, and guidance raised to 25%-30% growth for 2026

Q2 2026 saw 62% revenue growth and record bookings, driven by both defense and commercial markets. Gross margin was 39.1%, with strong cash reserves and no debt. Full-year revenue growth guidance was raised to 25%-30% on the back of a robust pipeline and expanding customer base.

Based on

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [OSS.US](https://longbridge.com/en/quote/OSS.US.md)
- [OSSL.US](https://longbridge.com/en/quote/OSSL.US.md)

## Related News & Research

- [OSS: Q2 2026 revenue jumped 62% year-over-year, but a $6.25M legal settlement drove a net loss](https://longbridge.com/en/news/294968835.md)
- [One Stop Systems Q2 revenue jumps on higher medical imaging sales; raises 2026 outlook](https://longbridge.com/en/news/294965090.md)
- [MRLN: Strong cash, milestone achievements, and rising revenue position for growth in autonomous aviation](https://longbridge.com/en/news/295852534.md)
- [FLT: Q2 2026 delivered record liquidity, strong sequential growth, and key advances in defence and technology](https://longbridge.com/en/news/295850323.md)
- [LTRN: OMAI spun out, clinical pipeline advanced, and Q2 operating loss fell 25% year-over-year](https://longbridge.com/en/news/295929109.md)